Semler Scientific, Inc.

SMLRNASDAQHealthcare

$20.33

$-1.04(-4.87%)

Market Cap$310745920

P/E Ratio—

52W High$65.98

52W Low$14.885

Avg Volume648K

Open$20.33

Beta1.32

Free Cash Flow Financials Revenue

Semler Scientific, Inc. (SMLR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

SMLR · free cash flow · updated Jun 8, 2026

Core FCF metrics

SMLR · FCF · TTM · margin & CAGR

Free cash flow was −$165.3M for FY2024 (fiscal year ending 2024-12-31), down 1073.1% year-over-year The FCF margin was -293.7%.

FY2024 Free Cash Flow−$165.3M▼ -1073.1% YoY

Trailing 12M (TTM)−$388.7Mtrailing 4 quarters sum

FCF Margin-293.7%−$165.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

SMLR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$24.4M(190M)−$165.3M▼ 1073.1%-293.7%

FY2023$17.8M(1M)$17.0M▲ +11.0%24.9%

FY2022$17.5M(2M)$15.3M▲ +0.5%27.0%

FY2021$16.1M(1M)$15.2M▲ +6.1%28.7%

FY2020$15.1M(1M)$14.4M▲ +30.2%37.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

SMLR · P/FCF · FCF yield · FCF per share

Semler Scientific, Inc. (SMLR) reported negative free cash flow of −$0.17B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

SMLR · cash flow statement · operating / investing / financing

For FY2024, Semler Scientific, Inc. generated $24.4M in operating cash flow and spent 190M in capital expenditures, yielding −$165.3M in free cash flow.

Operating Activities

+$24.4M

Cash from core business operations

2024-12-31

Investing Activities

−$190.0M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$117.2M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF ($24.4M) − |CapEx| (190M) = FCF (−$165.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

SMLR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Semler Scientific, Inc.YOU

SMLR

−$165.3M-1073.1%-293.7%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Semler Scientific, Inc. (SMLR) reported free cash flow of −$165.3M for FY2024 (fiscal year ending 2024-12-31), down 1073.1% year-over-year. The FCF margin was -293.7%.

Based on available data, Semler Scientific, Inc. has maintained positive free cash flow for at least 6 fiscal year(s). FCF peaked at $17.0M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

SMLR free cash flow · 8 questions

Semler Scientific, Inc. free cash flow was −$165.3M for FY2024, down 1073.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$388.7M.

SMLR free cash flowSMLR FCFSMLR FCF 2024SMLR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Semler Scientific, Inc. · Semler Scientific, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026